Skip to main content
SpringerLink
Log in

Hypothalamo-pituitary-adrenal axis in acute myocardial infarction treated by percutaneous transluminal coronary angioplasty: Effect of time of presentation

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Acute myocardial infarction (AMI) is associated with a stimulation of cortisol which lasts 24 hours in patients treated by thrombolysis. Percutaneous transluminal coronary angioplasty (PTCA) is an alternative treatment for AMI which reduces the length of myocardial ischemia. Our objective was the determination of the amplitude and duration of cortisol and other hormones of the hypothalamo-pituitaryadrenal (HPA) axis release in patients undergoing PTCA. These responses were also analyzed in relation with the time of onset of AMI. The effect of coronarography with or without angioplasty in patients without AMI was also studied. Plasma ACTH, cortisol, corticotropin-releasing hormone and arginine vasopressin levels were determined during the first 48 hours in 20 patients with first AMI, treated by PTCA and in 10 patients without AMI undergoing coronarography (and angioplasty in five of them). A strong stimulation of the HPA axis was observed in AMI patients, but the duration of cortisol secretion was significantly reduced (less than 8 hours) as compared with previous studies in patients treated with thrombolysis. A clear-cut ACTH-cortisol dissociation was also observed after the third hour. ACTH and cortisol stimulation was higher in patients admitted between 04:00 h and 16:00 h than in patients admitted between 16:00 h and 04:00 h In patients without AMI, coronarography induced a moderate, but significant short-lasting ACTH and cortisol stimulation. In conclusion, our data suggest that the degree of stimulation of the HPA axis may depend upon the type of treatment and the circadian rhythm of this axis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ceremuzynski L. Hormonal and metabolic reactions evoked by acute myocardial infarction. Circ. Res. 1981, 48: 767–776.

    Article  PubMed  CAS  Google Scholar 

  2. Logan R.W., Murdoch W.R. Blood levels of hydrocortisone, transaminases, and cholesterol after myocardial infarction. Lancet 1966, 2: 521–524.

    Article  PubMed  CAS  Google Scholar 

  3. Bailey R.B., Abernethy M.H., Beaven D.W. Adrenocortical response to the stress of an acute myocardial infarction. Lancet 1967, 1: 970–973.

    Article  PubMed  CAS  Google Scholar 

  4. Bain R.J.I., Fox J.P., Jagger J., Davies M.K., Littler W.A., Murray R.G. Serum cortisol levels predict infarct size and patient mortality. Int. J. Cardiol. 1992, 37: 145–150.

    Article  PubMed  CAS  Google Scholar 

  5. Wiener K. Plasma cortisol, corticosterone and urea in acute myocardial infarction: clinical and biochemical correlations. Clin. Chim. Acta 1977, 76: 243–250.

    Article  PubMed  CAS  Google Scholar 

  6. Klein A.J., Palmer L.A. Plasma cortisol in myocardial infarction: a correlation with shock and survival. Am. J. Cardiol. 1963, 11: 332–337.

    Article  PubMed  CAS  Google Scholar 

  7. Hansen B., Beck-Nielsen J., Juul J., Nielsen B.L., Nielsen F.U. Plasma hydrocortisone values in heart disease. Acta Med. Scand. 1969, 186: 411–416.

    Article  PubMed  CAS  Google Scholar 

  8. Prakash R., Parmley W.W., Horvat M., Swan H.J.C. Serum cortisol, plasma free acids, and urinary catecholamines as indicators of complications in acute myocardial infarction. Circulation 1972, 155: 736–745.

    Article  Google Scholar 

  9. Chopra M.P., Thadani U., Aber C.P., Portal R.W., Parkes J. Plasma cortisol, urinary 17-hydroxycorticoids, and urinary vanilyl mandelic acid after acute myocardial infarction. Br. Heart. J. 1972, 34: 992–997.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  10. Nitter-Hauge S., Kirkeby K., Alvsaker J.O., Aakwaag A. Plasma 11-hydroxycorticosteroids in acute myocardial infarction. Acta Med. Scand. 1972, 192: 535–538.

    Article  PubMed  CAS  Google Scholar 

  11. Donald R.A., Crozier I.G., Foy S.G. et al. Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction. Clin. Endocrinol. (Oxf.) 1994, 40: 499–504.

    Article  CAS  Google Scholar 

  12. Bain R.J.I., Poeppinghaus V.J.I., Jones G.M., Peaston M.J.T. Cortisol level predicts myocardial infarction in patients with ischaemic chest pain. Int. J. Cardiol. 1989, 25: 69–72.

    Article  PubMed  CAS  Google Scholar 

  13. Grines C.L. Primary angioplasty. The strategy of choice. N. Engl. J. Med. 1996, 335: 1313–1317.

    PubMed  CAS  Google Scholar 

  14. Caraty A., Grino M., Locatelli A., et al. Insulin-induced hypoglycaemia stimulates corticotropin-releasing factor and arginine vasopressin into hypophysial portal blood of conscious unrestrained rams. J. Clin. Invest. 1990, 85: 1716–1721.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  15. Robinson I.C.A.F. The development and evaluation of a sensitive and specific radioimmunoassay for oxytocin in unextracted plasma. Immunoassay. 1980, 1: 323–347.

    Article  CAS  Google Scholar 

  16. Oldroyd K.G., Harvey K., Gray C.E., Beastall G.H., Cobbe S.M. β Endorphin release in patients after spontaneous and provoked acute myocardial ischaemia. Br. Heart J. 1992, 67: 230–235.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  17. Dampney R.A.L. Functional organisation of central pathways regulating the cardiovascular system. Pharmacol. Rev. 1994, 74: 323–364.

    CAS  Google Scholar 

  18. Kiss JZ. Dynamism of chemoarchitecture in the hypothalamic paraventricular nucleus. Brain Res. Bull. 1998, 20: 966–708.

    Google Scholar 

  19. Charles C.J., Rogers S.J., Donald R.A., Ikram H., Prickett T., Richards A.M. Hypothalamo-pituitary-adrenal axis response to coronary artery embolization: an ovine model of acute myocardial infarction. J. Endocrinol. 1997, 152: 489–493.

    Article  PubMed  CAS  Google Scholar 

  20. Naito Y., Kukata J., Tamai S., et al. Biphasic changes in hypothalamo- pituitary-adrenal function during the early recovery period after major abdominal surgery. J. Clin. Endocrinol. Metab. 1991, 73: 111–117.

    Article  PubMed  CAS  Google Scholar 

  21. Roth-Isigkeit A., Schmucker P. Postoperative dissociation of blood levels of cortisol and adrenocorticotropin after coronary artery bypass grafting surgery. Steroids 1997, 62: 695–699.

    Article  PubMed  CAS  Google Scholar 

  22. Vermes I., Beishuizen A., Hampsink R.M., Haanen C. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J. Clin. Endocrinol. Metab. 1995, 80: 1238–1242.

    PubMed  CAS  Google Scholar 

  23. Charlton B.G. Adrenal cortical innervation and glucocorticoid secretion. J. Endocrinol. 1990, 126: 5–8.

    Article  PubMed  CAS  Google Scholar 

  24. Marx C., Ehrhart-Bornstein M., Scherbaum W.A., Bornstein S.R. Regulation of adrenocortical function by cytokines — relevance for immune-endocrine interaction. Horm. Metab. Res. 1998, 30: 416–420.

    Article  PubMed  CAS  Google Scholar 

  25. Guillen I., Blanes M., Gomez-Lechon M.J., Castell J.V. Cytokine signaling during myocardial infarction: sequential appearance of IL-1β and IL-6. Am. J. Physiol. 1995, 269: R229–R235.

    PubMed  CAS  Google Scholar 

  26. Antoni F.A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front. Neuroendocrinol. 1993, 14: 76–122.

    Article  PubMed  CAS  Google Scholar 

  27. Zing H.H. Vasopressin and oxytocin receptors. Baillere’s Clin. Endocrinol. Metab. 1996, 10: 75–96.

    Article  Google Scholar 

  28. Hader O., Bahr V., Hensen J., Hofbauer K.G., Oelkers WKH. Effects of a V1-vasopressin antagonist on ACTH release following vasopressin infusion or insulin-induced hypoglycemia in normal men. Acta. Endocrinol. (Copenh.) 1990, 123: 622–628.

    CAS  Google Scholar 

  29. Col J., Petein M., Van Eyll C., Cheron P., Charlier A.A., Pouleur H. Early changes in sodium and water balances in patients with acute myocardial infarction: relationship to haemodynamics and creatine kinase. Eur. J. Clin. Invest. 1984, 14: 247–254

    Article  PubMed  CAS  Google Scholar 

  30. Brar R.B., Stephanou A., Okosi A., Knight R., Lowry P.J., Latchman D.S. Regulation of the CRH promoter in ischaemic cardiac myocytes. Annual Meeting of the Endocrine Society 1998, 207 (Abst.)

    Google Scholar 

  31. Muller J.E., Stone P.H., Turi Z.G., et al. Circadian variation in the frequency of onset of acute myocardial infarction. N. Engl. J. Med. 1985, 313: 1315–1322.

    Article  PubMed  CAS  Google Scholar 

  32. Willich S.N., Linderer T., Wegscheider K., et al. Increased morning incidence of myocardial infarction in the ISAM study: absence with prior β-adrenergic blockade. Circulation. 1989, 80: 853–858.

    Article  PubMed  CAS  Google Scholar 

  33. Boden G. Hormonal and metabolic disturbances during acute and subacute myocardial infarction in man. Diabetologia 1971, 2: 240–246.

    Article  Google Scholar 

  34. Oswald G.A., Smith C.C.T., Betteridge D.J., Yudkin J.S. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br. Med. J. 1986, 293: 917–922.

    Article  CAS  Google Scholar 

  35. Fimognari F.P., Piccirillo G., et al. Associated daily biosynthesis of cortisol and thromboxane A2: a preliminary report. J. Lab. Clin. Med. 1996, 128: 115–121.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Assistance Publique Hôpitaux de Marseille, Institut Fédératif Jean Roche, School of Medicine, Université de la Méditerranée, Marseille, France

    F. Paganelli, P. Barnay, P. Sbragia, R. Gelisse & S. Levy

  2. Department of Endocrinology, Metabolic Diseases and Nutrition, Assistance Publique Hôpitaux de Marseille, Institut Fédératif Jean Roche, School of Medicine, Université de la Méditerranée, Chemin des Bourrely, 13915, Marseille Cedex 20, France

    C. Frachebois, S. Boullu &  Charles Oliver M.D.

  3. Department of Internal Medicine, Assistance Publique Hôpitaux de Marseille, Institut Fédératif Jean Roche, School of Medicine, Université de la Méditerranée, Marseille, France

    J. G. Velut

  4. Laboratory of Biochemistry, Assistance Publique Hôpitaux de Marseille, Institut Fédératif Jean Roche, School of Medicine, Université de la Méditerranée, Marseille, France

    J. P. Rosso

  5. INSERM U 501, Assistance Publique Hôpitaux de Marseille, Institut Fédératif Jean Roche, School of Medicine, Université de la Méditerranée, Marseille, France

    N. Sauze & M. Grino

Authors
  1. F. Paganelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Frachebois
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. G. Velut
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Boullu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Sauze
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. P. Rosso
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Barnay
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P. Sbragia
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. R. Gelisse
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M. Grino
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. S. Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Charles Oliver M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles Oliver M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paganelli, F., Frachebois, C., Velut, J.G. et al. Hypothalamo-pituitary-adrenal axis in acute myocardial infarction treated by percutaneous transluminal coronary angioplasty: Effect of time of presentation. J Endocrinol Invest 26, 407–413 (2003). https://doi.org/10.1007/BF03345195

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345195

Key-words

Search

Navigation